Background Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma,
with median age at diagnosis in the seventh decade. FL in young adults (YAs), defined as …

Background This study was aimed at investigating the clinical features and outcomes of
follicular lymphoma (FL) patients younger than 40 years, which have not been extensively …

Limited data exist to describe the clinical features and outcomes for elderly patients with
follicular lymphoma (FL). The Follicular Lymphoma Analysis of Surrogacy Hypothesis …

Summary Data from the National LymphoCare Study (a prospective, multicentre registry that
enrolled follicular lymphoma (FL) patients from 2004 to 2007) were used to determine …

Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …

Background Few studies have evaluated real-world treatment patterns and survival in
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …

We assessed stage-specific trends in primary therapy and relative survival among adult
follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N …

Disease overview: Follicular lymphoma (FL) is generally an indolent B‐cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …